Back to User profile » Dr Caterina Lanna
Papers published by Dr Caterina Lanna:
Efficacy and Safety of Apremilast in Oncological Patients with Moderate-to-Severe Plaque Psoriasis: A 5 years Retrospective Observational Study
Lanna C, Rivieccio A, Vultaggio M, Gaeta Shumak R, Bonacci FM, Artosi F, Borselli C, Costanza G, Bianchi L, Campione E
Clinical, Cosmetic and Investigational Dermatology 2025, 18:1231-1238
Published Date: 20 May 2025
Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series
Matteini E, Diluvio L, Lambiase S, Cioni A, Gaeta Shumak R, Costanza G, Lanna C, Caldarola G, Bianchi L, Campione E
Clinical, Cosmetic and Investigational Dermatology 2024, 17:2225-2230
Published Date: 5 October 2024
Experimental Pharmacological Management of Psoriasis
Campione E, Cosio T, Di Prete M, Lanna C, Dattola A, Bianchi L
Journal of Experimental Pharmacology 2021, 13:725-737
Published Date: 26 July 2021
Small Molecules, Big Promises: Improvement of Psoriasis Severity and Glucidic Markers with Apremilast: A Case Report
Lanna C, Cesaroni GM, Mazzilli S, Bianchi L, Campione E
Diabetes, Metabolic Syndrome and Obesity 2019, 12:2685-2688
Published Date: 17 December 2019
The Effectiveness of a New Topical Formulation Containing GSH-C4 and Hyaluronic Acid in Seborrheic Dermatitis: Preliminary Results of an Exploratory Pilot Study
Campione E, Mazzilli S, Lanna C, Cosio T, Palumbo V, Cesaroni G, Lozzi F, Diluvio L, Bianchi L
Clinical, Cosmetic and Investigational Dermatology 2019, 12:881-885
Published Date: 16 December 2019
Omalizumab for chronic spontaneous urticaria in “complex” patients: data from real-life clinical practice
Vollono L, Piccolo A, Lanna C, Esposito M, Bavetta M, Campione E, Bianchi L, Diluvio L
Drug Design, Development and Therapy 2019, 13:3181-3186
Published Date: 6 September 2019